(Total Views: 950)
Posted On: 03/03/2020 5:00:10 PM
Post# of 148870
In regards to buyout potential.
1. Let's assume CYDY would accept $5 billion for a buyout.
2. Let's also assume that a BP would consider $5 billion for Leronlimab
3. No BP CEO is going to go to their board and say I want to pay $5B for a a little OTC company with a $700 million MC. Doesn't matter how good the drug is. CEO's don't want to look dumb. The MC is only $700 million because except for CYDY managment and shareholders nobody believes Leronlimab is a wonder drug. Maybe some BP's do but they certainly aren't going to do anything to give Leronlimab and CYDY credibility.
4. If someone with enough credibility to create awareness labels Leronlimab the next big wonder drug, the MC will rocket higher and then BP will be in a position to offer something that will be hard to turn down. Until the market cap gets closer to the true value of Leronlimab, a BO doesn't seem possible.
1. Let's assume CYDY would accept $5 billion for a buyout.
2. Let's also assume that a BP would consider $5 billion for Leronlimab
3. No BP CEO is going to go to their board and say I want to pay $5B for a a little OTC company with a $700 million MC. Doesn't matter how good the drug is. CEO's don't want to look dumb. The MC is only $700 million because except for CYDY managment and shareholders nobody believes Leronlimab is a wonder drug. Maybe some BP's do but they certainly aren't going to do anything to give Leronlimab and CYDY credibility.
4. If someone with enough credibility to create awareness labels Leronlimab the next big wonder drug, the MC will rocket higher and then BP will be in a position to offer something that will be hard to turn down. Until the market cap gets closer to the true value of Leronlimab, a BO doesn't seem possible.
(3)
(0)Scroll down for more posts ▼
